Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Mannelli P, Peindl KS, Wu LT.

Subst Abuse Rehabil. 2011 Jun;2011(2):113-123.

2.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

3.

Sustained-release naltrexone for opioid dependence.

Lobmaier P, Kornør H, Kunøe N, Bjørndal A.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006140. doi: 10.1002/14651858.CD006140.pub2. Review.

PMID:
18425938
4.

The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.

Mannelli P, Peindl K, Wu LT, Patkar AA, Gorelick DA.

Am J Drug Alcohol Abuse. 2012 May;38(3):200-5. doi: 10.3109/00952990.2011.644003. Epub 2012 Jan 10.

5.

Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.

Lobmaier PP, Kunøe N, Gossop M, Waal H.

CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x. Review.

PMID:
21554565
6.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

7.

Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.

Soyka M, Rösner S.

Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. Review.

PMID:
19630726
8.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD001333. doi: 10.1002/14651858.CD001333.pub4. Review.

PMID:
21491383
9.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD001333. doi: 10.1002/14651858.CD001333.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(4):CD001333.

PMID:
21328250
10.

A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence.

Larney S, Gowing L, Mattick RP, Farrell M, Hall W, Degenhardt L.

Drug Alcohol Rev. 2014 Mar;33(2):115-28. doi: 10.1111/dar.12095. Epub 2013 Dec 3. Review.

PMID:
24299657
11.

Sustained-release naltrexone: novel treatment for opioid dependence.

Comer SD, Sullivan MA, Hulse GK.

Expert Opin Investig Drugs. 2007 Aug;16(8):1285-94. Review.

PMID:
17685876
12.

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP.

Arch Gen Psychiatry. 2006 Feb;63(2):210-8.

13.

Naltrexone extended-release injection: an option for the management of opioid abuse.

Taylor R Jr, Raffa RB, Pergolizzi JV Jr.

Subst Abuse Rehabil. 2011 Dec 6;2:219-26. doi: 10.2147/SAR.S17920. eCollection 2011. Review.

14.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001333. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD001333.

PMID:
16437431
15.

Long-acting injectable naltrexone for the management of patients with opioid dependence.

Kjome KL, Moeller FG.

Subst Abuse. 2011;5:1-9. doi: 10.4137/SART.S5452. Epub 2011 Feb 6.

16.

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.

Johansson BA, Berglund M, Lindgren A.

Addiction. 2006 Apr;101(4):491-503. Review.

PMID:
16548929
17.

Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?

Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.

Am J Drug Alcohol Abuse. 2006;32(4):503-17.

PMID:
17127538
18.

Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.

Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.

Am J Drug Alcohol Abuse. 2012 May;38(3):187-99. doi: 10.3109/00952990.2011.653426. Epub 2012 Mar 12. Review.

19.

Maintenance medication for opiate addiction: the foundation of recovery.

Bart G.

J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. Review.

20.

Opioid antagonists with minimal sedation for opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2002;(2):CD002021. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD002021.

PMID:
12076431

Supplemental Content

Support Center